
The Chief Executives of Pfizer, Sanofi and Bristol-Myers Squibb have said that they will join four other pharma execs in …

Richard Ridinger, the CEO of Swiss biotechnology firm Lonza Group, will step down from his position in March of this …

Genetech, the biotech subsidiary of Swiss firm Roche, has named its new CEO, revealing that Alexander Hardy will be returning …

The Cambridge, Massachusetts pharma firm Ironwood Pharmaceuticals has announced the appointment of AstraZeneca veteran Mark Mallon in preparation for the …

Two of AstraZeneca’s senior executives have been poached by the biotech firms Ironwood Pharmaceuticals and Immunocore, as the two biotechnology …

Almost half a year since it was revealed that Gilead’s Dr John Milligan would be stepping down from his role …

The CEO of American generics firm Akorn Inc has stepped down following a ruling from the Delaware Supreme Court declaring …
Pharmafocus talked to Joe Wiley, CEO and founder of Amryt Pharma as he retraced his journey from medical student in …

Ian Read is set to step down from his position as Chief Executive Officer (CEO) of American pharma firm Pfizer, …

Ian Read is set to step down from his position as Chief Executive Officer (CEO) of American pharma firm Pfizer, …

The Watertown Massachusetts-based stapled peptide therapeutics specialist Aileron Therapeutics has appointed former SVP, Chief Medical & Scientific Officer Dr Manuel …

The Cambridge Massachusetts-based biopharmaceutical company Rheos Medicines has appointed former Roche Senior Vice President and Global R&D Head, Dr Sanjay …

The Massachusetts-based oncology specialist Agios Pharmaceuticals has appointed former Celgene President and COO Jacqualyn Fouse as their new Chief Executive …

The CEO of American multinational Pfizer has said that he believes the Trump administration will eliminate rebates on prescription drug …

Silence Therapeutics has appointed Dr David Horn Solomon as its new Chief Executive Officer (CEO), effective immediately. Solomon will head …